CM Life Sciences II Inc. (CMII)
NASDAQ: CMII
· Real-Time Price · USD
10.63
-0.67 (-5.93%)
At close: Sep 02, 2021, 6:00 AM
Company Description
CM Life Sciences II Inc. does not have significant operations.
It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector.
The company was incorporated in 2020 and is based in New York, New York.
CM Life Sciences II Inc.
| Country | United States |
| IPO Date | Apr 15, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Eli Decatur Casdin |
Contact Details
Address: 667 Madison Avenue New York City, New York United States | |
| Website | http://ii.cmlifesciencesspac.com |
Stock Details
| Ticker Symbol | CMII |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001837412 |
| CUSIP Number | 125842104 |
| ISIN Number | US1258421049 |
| Employer ID | 85-4298912 |
| SIC Code | 8731 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 29, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 29, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 16, 2024 | 15-12G | Filing |
| Jan 09, 2024 | 4 | Filing |
| Jan 09, 2024 | 4 | Filing |
| Jan 09, 2024 | 4 | Filing |
| Jan 09, 2024 | 4 | Filing |
| Jan 09, 2024 | 4 | Filing |
| Jan 09, 2024 | 4 | Filing |